tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Latest News

PharmaCyte Biotech Releases HealthWatch Segment Featured on Discovery Channel

PharmaCyte Biotech Releases HealthWatch Segment Featured on Discovery Channel

SILVER SPRING, MD, June 30, 2015 – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that its technology and treatments were featured on the Discovery Channel and ION Network this morning. Discovery Channel and ION Network’s news magazine series, “NewsWatch,” aired the company’s story in a 3:42 “HealthWatch” segment that highlighted the companies efforts to bring both cancer and diabetes treatments to market.

For those who were unable to watch the segment on Discovery Channel or ION Netowork, here is the link to view it: www.stockmarketmediagroup.com/media.

PharmaCyte Biotech’s Chief Executive Officer, Kenneth L. Waggoner, commented on the company getting nationwide attention, “HealthWatch did a thorough job telling our story with the level of enthusiasm and attention to detail that PharmaCyte Biotech embraces in everything it does. We are extremely pleased that as many as 96 million households in the U.S. have had an opportunity to learn of our unique technology. The key to our success is having our story told in a way that will facilitate getting our treatments to patients who so desperately need them.”

Each edition of NewsWatch, a source for breaking consumer, technology, travel, health and entertainment news since 1990, reaches more than 96 million U.S. households. To date, over 700 million people have viewed the NewsWatch series, making it one of the most successful independently produced news magazines on television.

0
ContactUs.com